Skip to main content

Table 2 Logistic regression modal of the association between fatigue and clinical characteristics in PD patients

From: Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment

Variable

Univariate analysis

 

Multivariate analysis

 

odds ratio

P -value

odds ratio

P -value

Female sex (n= 222)

1.594 (0.926–2.742)

0.092

  

Age, y (n= 222)

1.009 (0.982–1.037)

0.522

  

Onset age, y (n= 222)

1.000 (0.974–1.027)

0.992

  

Duration of disease, y (n= 222)

1.100 (1.000–1.208)

0.049*

  

Education, y (n= 222)

0.935 (0.864–1.011)

0.091

  

LEDD (mg/day) (n= 222)

1.001 (1.000–1.002)

0.083

  

H-Y stage (n= 222)

1.578 (1.102–2.258)

0.013*

  

UPDRS total score (n= 222)

1.033 (1.018–1.048)

<0.001*

  

UPDRS part I (n= 222)

1.333 (1.159–1.533)

<0.001*

  

UPDRS part II (n= 222)

1.122 (1.059–1.189)

<0.001*

  

UPDRS part III (n= 222)

1.036 (1.016–1.056)

<0.001*

  

UPDRS part IV (n= 222)

1.210 (1.049–1.396)

0.009*

  

HAMD score (n= 177)

1.079 (1.016–1.146)

0.013*

  

PDSS (n= 177)

0.967 (0.954–0.981)

<0.001*

0.974 (0.959–0.989)

0.001

MoCA score (n= 222)

0.948 (0.890–1.009)

0.094

  
  1. Figures in parentheses indicate 95 % confidence intervals. *Significant difference. H-Y stage Hoehn & Yahr staging, LEDD levodopa equivalent daily dosage, UPDRS Unified Parkinson’ Disease Rating Scale, MoCA Montreal Cognitive Assessment, HAMD Hamilton Depression Scale score, PDSS Parkinson’s Disease Sleep Scale